Akèy › Dyabèt tip 1 › Tennessee
Etid klinik pou Dyabèt tip 1 nan Tennessee
11 etid pou Dyabèt tip 1 ap chèche patisipan nan sit nan Tennessee.
Vil nan Tennessee
Tèks ofisyèl etid la (Anglè)
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- AM Diabetes & Endocrinology Center- Site Number : 8400004, Bartlett
Ap rekriteFaz 3
Laj 1 a 25 · Tout sèks · Mizajou Sep 14, 2026 · NCT07088068CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- University Diabetes & Endocrine Consultants, Chattanooga
- Le Bonhuer Children's, Memphis
Ap rekriteFaz 1/2
Laj 12 a 35 · Tout sèks · Mizajou Sep 11, 2026 · NCT06783309Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
- Vanderbilt University, Nashville
Ap rekriteFaz 2
Laj 8 a 45 · Tout sèks · Mizajou Sep 8, 2026 · NCT07142252Family Intervention for Black Teens With Type 1 Diabetes
- LeBonheur Children's Hospital, Memphis
- University of Tennessee Health Science Center-Memphis, Memphis
Ap rekrite
Laj 10 a 14 · Tout sèks · Mizajou Aug 27, 2026 · NCT06275412Registry for Stage 2 Type 1 Diabetes
- AM Diabetes & Endocrinology Center- Site Number : 8400012, Bartlett
- Vanderbilt University Medical Center- Site Number : 8400023, Nashville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 13, 2026 · NCT06481904Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 5, 2026 · NCT06852950Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1 bonèVolontè an sante akeyi
Laj 18 a 60 · Tout sèks · Mizajou Dec 23, 2025 · NCT06609356Discovery Diabetes
- Vanderbilt University, Nashville
Ap rekrite
Laj 13 a 21 · Tout sèks · Mizajou Dec 23, 2025 · NCT07116434GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 1 bonè
Laj 12 a 50 · Tout sèks · Mizajou Dec 18, 2025 · NCT06338553Sleep Coach for Adolescents With Type 1 Diabetes
- Vanderbilt University Medical Center, Nashville
Ap rekrite
Laj 11 a 17 · Tout sèks · Mizajou Oct 1, 2025 · NCT06516614TrialNet Pathway to Prevention of T1D
- Vanderbilt University, Nashville
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 2 a 45 · Tout sèks · Mizajou Jul 1, 2025 · NCT00097292Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.